Aberdeen Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Sell |
12,003
-336
| -3% | -$62.4K | 1.48% | 15 |
|
|
2025
Q1 | $2.59M | Sell |
12,339
-97
| -0.8% | -$20.3K | 1.78% | 11 |
|
|
2024
Q4 | $2.21M | Sell |
12,436
-559
| -4% | -$99.3K | 1.51% | 14 |
|
|
2024
Q3 | $2.57M | Sell |
12,995
-1,997
| -13% | -$394K | 1.69% | 10 |
|
|
2024
Q2 | $2.57M | Buy |
14,992
+53
| +0.4% | +$9.09K | 1.74% | 11 |
|
|
2024
Q1 | $2.72M | Buy |
14,939
+1,503
| +11% | +$274K | 1.58% | 12 |
|
|
2023
Q4 | $2.08M | Sell |
13,436
-1,547
| -10% | -$240K | 1.51% | 12 |
|
|
2023
Q3 | $2.23M | Buy |
14,983
+3
| +0% | +$447 | 1.68% | 12 |
|
|
2023
Q2 | $2.02M | Buy |
14,980
+3
| +0% | +$404 | 1.46% | 14 |
|
|
2023
Q1 | $2.39M | Sell |
14,977
-97
| -0.6% | -$15.5K | 1.78% | 10 |
|
|
2022
Q4 | $2.44M | Sell |
15,074
-1,957
| -11% | -$316K | 1.84% | 10 |
|
|
2022
Q3 | $2.29M | Buy |
17,031
+3
| +0% | +$403 | 2.01% | 9 |
|
|
2022
Q2 | $2.61M | Buy |
17,028
+3
| +0% | +$459 | 2.07% | 9 |
|
|
2022
Q1 | $2.76M | Buy |
17,025
+3
| +0% | +$486 | 1.88% | 10 |
|
|
2021
Q4 | $2.31M | Buy |
17,022
+3
| +0% | +$406 | 1.5% | 14 |
|
|
2021
Q3 | $1.84M | Sell |
17,019
-292
| -2% | -$31.5K | 1.78% | 11 |
|
|
2021
Q2 | $1.95M | Buy |
17,311
+3
| +0% | +$338 | 1.8% | 13 |
|
|
2021
Q1 | $1.87M | Sell |
17,308
-420
| -2% | -$45.5K | 1.49% | 15 |
|
|
2020
Q4 | $1.9M | Buy |
17,728
+420
| +2% | +$45K | 1.43% | 14 |
|
|
2020
Q3 | $1.52M | Buy |
17,308
+4
| +0% | +$350 | 1.44% | 18 |
|
|
2020
Q2 | $1.7M | Buy |
17,304
+56
| +0.3% | +$5.5K | 1.82% | 10 |
|
|
2020
Q1 | $1.31M | Sell |
17,248
-230
| -1% | -$17.5K | 1.6% | 13 |
|
|
2019
Q4 | $1.55M | Buy |
+17,478
| New | +$1.55M | 1.15% | 14 |
|